The expression of rna-binding protein hur in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis

Oncology

Volumn 76, Issue 6, 2009, Pages 420-429

  Wang, Jun ^a,d   Zhao, Weipeng ^a   Guo, Yan ^a   Zhang, Bicheng ^a,c   Xie, Qichao ^a   Xiang, Debing ^b   Gao, Jianfei ^c   Wang, Baocheng ^d   Chen, Zhengtang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^d GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

HuR; mRNA stability; Non small cell lung cancer; Vascular endothelial growth factor C

Indexed keywords

HUR PROTEIN; RNA BINDING PROTEIN; SMALL INTERFERING RNA; VASCULOTROPIN C; ELAV-LIKE PROTEIN 1; MEMBRANE ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RNA STABILITY; WESTERN BLOTTING; ADENOCARCINOMA; BIOSYNTHESIS; CHEMISTRY; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; ANTIGENS, SURFACE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; RNA-BINDING PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 65449184997     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000216837     Document Type: Article

References (36)

1. Benjamin D, Moroni C: mRNA stability and cancer: an emerging link? Expert Opin Biol Ther 2007;7:1515-1529.
2. Brennan CM, Steitz JA: HuR and mRNA stability. Cell Mol Life Sci 2001;58:266-277.
3. Katsanou V, Papadaki O, Milatos S, Black-shear PJ, Anderson P, Kollias G, Kontoyian-nis DL: HuR as a negative posttranscription-al modulator in inflammation. Mol Cell 2005;19:777-789.
4. Wang W, Caldwell MC, Lin S, Furneaux H, Gorospe M: HuR regulates cyclin A and cyclin B1mR NA stability during cell proliferation. EMBO J 2000;19:2340-2350.
5. López de Silanes I, Fan J, Yang X, Zonder-man AB, Potapova O, Pizer ES, Gorospe M: Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 2003;22:7146-7154.
6. Niesporek S, Kristiansen G, Thoma A, Weichert W, Noske A, Buckendahl AC, Jung K, Stephan C, Dietel M, Denkert C: Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2expression. Int J Oncol 2008;32:341-347.
7. Heinonen M, Bono P, Narko K, Chang SH, Lundin J, Joensuu H, Fu rneau x H, Hla T, Haglund C, Ristimäki A: Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res 2005;65:2157-2161.
8. Denkert C, Weichert W, Pest S, Koch I, Licht D, Köbel M, Reles A, Sehouli J, Dietel M, Hauptmann S: Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclo-ox ygenase 2expression. Cancer Res 2004;64:189-195.
9. Denkert C, Koch I, von Keyserlingk N, Noske A, Niesporek S, Dietel M, Weichert W: Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod Pathol 2006;19:1261-1269.
10. Heinonen M, Fagerholm R, Aaltonen K, Kil-pivaara O, Aittomäki K, Blomqvist C, Heik-kilä P, Haglund C, Nevanlinna H, Ristimäki A: Prognostic role of HuR in hereditary breast cancer. Clin Cancer Res 2007;13:6959-6963.
11. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-198.
12. Schoppmann SF, Birner P, Stöckl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D: Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumor-al lymphangiogenesis. Am J Pathol 2002;161:947-956.
13. Alitalo K, Tammela T, Petrova TV: Lym-phangiogenesis in development and human disease. Nature 2005;438:946-953.
14. Mylona E, Alexandrou P, Mpakali A, Gian-nopoulou I, Liapis G, Markaki S, Keramopoulos A, Nakopoulou L: Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and-D and VEGF receptor 3in invasive breast carcinoma. Eur J Surg Oncol 2007;33:294-300.
15. Chen Z, Varney ML, Backora MW, Cowan K, Solheim JC, Talmadge JE, Singh RK: Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tu mor lympha ngiogenesis and spontaneous metastasis and enhances survival. Cancer Res 2005;65:9004-9011.
16. Ristimäki A, Narko K, Enholm B, Joukov V, Alitalo K: Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 1998;273:8413-8418.
17. Chilov D, Kukk E, Taira S, Jeltsch M, Kau-konen J, Palotie A, Joukov V, Alitalo K: Ge-nomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem 1997;272:25176-25183.
18. Orlandini M, Semboloni S, Oliviero S: Betacatenin inversely regulates vascular endothelial growth factor-D mRNA stability. J Biol Chem 2003;278:44650-44656.
19. Vumbaca F, Phoenix KN, Rodriguez-Pinto D, Han DK, Claffey KP: Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis. Mol Cell Biol 2008;28:772-783.
20. Denkert C, Weichert W, Winzer KJ, Mül-ler BM, Noske A, Niesporek S, Kristiansen G, Guski H, Dietel M, Hauptmann S: Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2expression in human breast carcinoma. Clin Cancer Res 2004;10:5580-5586.
21. Furudoi A, Tanaka S, Haruma K, Kitadai Y, Yoshihara M, Chayama K, Shimamoto F: Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology 2002;62:157-166.
22. Da MX, Wu XT, Wang J, Guo TK, Zhao ZG, Luo T, Zhang MM, Qian K: Expression of cyclooxygenase-2and vascular endothelial growth factor-C correlates with lymphangi-ogenesis and lymphatic invasion in human gastric cancer. Arch Med Res 2008;39:92-99.
23. Cha HS, Bae EK, Koh JH, Chai JY, Jeon CH, Ahn KS, Kim J, Koh EM: Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes. J Rheumatol 2007;34:16-19.
24. Tsai PW, Shiah SG, Lin MT, Wu CW, Kuo ML: Up-regulation of vascular endothelial growth factor C in breast cancer cells by he-regulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem 2003;278:5750-5759.
25. Zhao B, Ma A, Cai J, Boulton M: VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells. Br J Ophthalmol 2006;90:1052-1059.
26. Nabors LB, Suswam E, Huang Y, Yang X, Johnson MJ, King PH: Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR. Cancer Res 2003;63:4181-4187.
27. Chen CY, Shyu AB: AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 1995;20:465-470.
28. Mrena J, Wiksten JP, Thiel A, Kokkola A, Pohjola L, Lundin J, Nordling S, Ristimäki A, Haglund C: Cyclooxygenase-2is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR. Clin Cancer Res 2005;11:7362-7368.
29. Goldberg-Cohen I, Furneauxb H, Levy AP: A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. J Biol Chem 2002;277:13635-13640.
30. Blaxall BC, Dwyer-Nield LD, Bauer AK, Bohlmeyer TJ, Malkinson AM, Port JD: Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol Carcinog 2000;28:76-83.
31. Huwiler A, Akool el S, Aschrafi A, Hamada FM, Pfeilschifter J, Eberhardt W: ATP potentiates interleukin-1beta-induced MMP-9expression in mesangial cells via recruitment of the ELAV protein HuR. J Biol Chem 2003;278:51758-51769.
32. Cok SJ, Acton SJ, Morrison AR: The proximal region of the 3′-untranslated region of cyclooxygenase-2is recognized by a multi-meric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U. J Biol Chem 2003;278:36157-36162.
33. Suswam EA, Nabors LB, Huang Y, Yang X, King PH: IL-1beta induces stabilization of IL-8mRNA in malignant breast cancer cells via the 3′ untranslated region: involvement of divergent RNA-binding factors HuR KSRP and TIAR. Int J Cancer 2005;113:911-919.
34. Wang W, Yang X, Kawai T, López de Silanes I, Mazan-Mamczarz K, Chen P, Chook YM, Quensel C, Köhler M, Gorospe M: AMP-activated protein kinase-regulated phosphorylation and acetylation of importin alpha1:involvement in the nuclear import of RNA-binding protein HuR. J Biol Chem 2004;279:48376-48388.
35. Subbaramaiah K, Marmo TP, Dixon DA, Dannenberg AJ: Regulation of cyclooxge-nase-2mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR. J Biol Chem 2003;278:37637-37647.
36. van der Giessen K, Di Marco S, Clair E, Gallouzi IE: RNAi-mediated HuR depletion leads to the inhibition of muscle cell differentiation. J Biol Chem 2003;278:47119-47128.